» Articles » PMID: 32276474

Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells

Abstract

Piperine, an amide extracted from the Piper spices, exhibits strong anti-tumor properties. However, its effect on the epithelial-mesenchymal transition (EMT) process has never been investigated. Herein, we evaluate the toxic effect of piperine on lung adenocarcinoma (A549), breast adenocarcinoma (MDA-MB-231) and hepatocellular carcinoma (HepG2) cell lines, as well as its ability to inhibit EMT-related events induced by TGF-β1 treatment. The cell viability was investigated by MTT assay. Protein expression was evaluated by Western blot. Gene expression was monitored by real-time PCR. Zymography assay was employed to detect metalloproteinase (MMP) activity in conditioned media. Cell motility was assessed by the wound-healing and phagokinetic gold sol assays. The results revealed that piperine was cytotoxic in concentrations over 100 µM, showing IC50 values for HepG2, MDA-MB-231 and A549 cell lines of 214, 238 and 198 µM, respectively. In order to investigate whether piperine would reverse the TGF-β1 induced-EMT, the A549 cell line was pretreated with sublethal concentrations of the natural amide followed by the addition of TGF-β1. Besides disrupting EMT-related events, piperine also inhibited both ERK 1/2 and SMAD 2 phosphorylation. These results suggest that piperine might be further used in therapeutic strategies for metastatic cancer and EMT-related disorders.

Citing Articles

The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells.

Effat H, El Houseini M, Abohashem R Indian J Clin Biochem. 2025; 40(1):32-45.

PMID: 39835241 PMC: 11741974. DOI: 10.1007/s12291-024-01212-0.


Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells.

Hakeem A, El-Kersh D, Hammam O, Elhosseiny A, Zaki A, Kamel K Sci Rep. 2024; 14(1):18181.

PMID: 39107323 PMC: 11303729. DOI: 10.1038/s41598-024-65508-0.


Molecular Aspects of Piperine in Signaling Pathways Associated with Inflammation in Head and Neck Cancer.

Gusson-Zanetoni J, Cardoso L, de Sousa S, de Melo Moreira Silva L, de Oliveira Martinho J, Henrique T Int J Mol Sci. 2024; 25(11).

PMID: 38891950 PMC: 11172343. DOI: 10.3390/ijms25115762.


Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.

Runa F, Ortiz-Soto G, de Barros N, Kelber J Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543112 PMC: 10975212. DOI: 10.3390/ph17030326.


Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds.

Choudhary N, Bawari S, Burcher J, Sinha D, Tewari D, Bishayee A Cancers (Basel). 2023; 15(15).

PMID: 37568796 PMC: 10417502. DOI: 10.3390/cancers15153980.


References
1.
Umar S, Sarwar A, Umar K, Ahmad N, Sajad M, Ahmad S . Piperine ameliorates oxidative stress, inflammation and histological outcome in collagen induced arthritis. Cell Immunol. 2013; 284(1-2):51-9. DOI: 10.1016/j.cellimm.2013.07.004. View

2.
Chaudhury A, Howe P . The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma. IUBMB Life. 2009; 61(10):929-39. PMC: 2810629. DOI: 10.1002/iub.239. View

3.
Ma J, Zeng S, Zhang Y, Deng G, Shen H . Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin. Tumour Biol. 2015; 37(5):6177-84. DOI: 10.1007/s13277-015-4458-z. View

4.
Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y . Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine. 2011; 19(1):83-7. DOI: 10.1016/j.phymed.2011.06.031. View

5.
Ding Y, Gelfenbeyn K, Freire-de-Lima L, Handa K, Hakomori S . Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin. FEBS Lett. 2012; 586(13):1813-20. PMC: 3377767. DOI: 10.1016/j.febslet.2012.05.020. View